FDA Approved: DEFERASIROX — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for deferasirox from Zydus Pharmaceuticals USA Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX (DEFERASIROX)